Early Phase 1 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have prostate cancer that has spread to other parts of the body, is no longer responding to hormone-suppressing treatments and/or chemotherapy, and is getting worse over time.
- People whose cancer has been confirmed by a specific type of scan (called a 68Ga-PSMA PET/CT scan) to have spread to distant parts of the body and to show high levels of a protein marker called PSMA, with this scan done within one week before receiving the trial treatment.
Who may not be able to join:
- People whose cancer shows up on a different type of scan (called an FDG PET scan) but does not also show the PSMA marker on the PSMA scan.
- People who have received another type of radioactive treatment within the past 6 months.
- People whose bone marrow, liver, or kidney function is significantly reduced, including those with low red blood cell levels (haemoglobin below 9.0 g/dL), low white blood cell counts (below 2.5×10⁹/L), low platelet counts (below 100×10⁹/L), or reduced kidney function as measured by a blood marker called creatinine (above 100 μmol/L).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhaohui Zhu, MD, Peking Union Medical College Hospital
Phone: 86-13611093752
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dosimetry of normal organs and tumors; Hematologic adverse events collection; Hepatic and renal toxic events collection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.